BNB Standard adds Zhao Changpeng to insider report
BNB Standard Corp (BNC) reported that YZiLabs Management Ltd. (YZi Labs) exercised 2,180,631 Strategic Advisor Warrants and 5,418,633 Pre-Funded Warrants on September 17, 2026, each at an exercise price of $0.00001 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BNB Standard Corp (BNC) reported that YZiLabs Management Ltd. (YZi Labs) exercised 2,180,631 Strategic Advisor Warrants and 5,418,633 Pre-Funded Warrants on September 17, 2026, each at an exercise price of $0.00001 per share. The exercises represented the same respective numbers of common shares. Afterward, reported remaining positions were 1,383,728 Strategic Advisor Warrants and 2,331,877 Pre-Funded Warrants.
The issuer agreed on September 17, 2026, to waive the required 61 days’ notice for increases to the beneficial ownership limitations under both warrant classes; their stated limits were 9.99% and 19.99%, respectively. The amendment adds Zhao Changpeng, a 10% owner, as a reporting person and otherwise leaves the original Form 4 information unchanged.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| In-the-Money Exercise | Strategic Advisor Warrants F1, F4, F5, F2, F3 | 2,180,631 | -- | -- |
| In-the-Money Exercise | Pre-Funded Warrants F1, F6, F5, F2, F3 | 5,418,633 | -- | -- |
| In-the-Money Exercise | Common Stock, par value $0.00001 per share F1, F2, F3 | 2,180,631 | -- | -- |
| In-the-Money Exercise | Common Stock, par value $0.00001 per share F1, F2, F3 | 5,418,633 | -- | -- |
| holding | Stapled Warrants F7, F5, F2, F3 | -- | -- | -- |
Footnotes (7)
- F1. The exercise price is $0.00001 per share.
- F2. This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company ("YZi Labs") and Changpeng Zhao ("Mr. Zhao"), a citizen of the United Arab Emirates (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- F3. Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.
- F4. The Strategic Advisor Warrants are immediately exercisable at an exercise price equal to $0.00001 per share and may be exercised at any point on or prior to 5:00 p.m. on August 5, 2030, subject to the SAW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Strategic Advisor Warrants, the holder may increase or decrease the SAW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 9.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Strategic Advisor Warrants is 9.99% of the Issuer's then outstanding shares of Common Stock (the "SAW Beneficial Ownership Limitation"). On September 17, YZi Labs exercised 2,180,631 Strategic Advisor Warrants, representing 2,180,631 shares of Common Stock, at an exercise price of $0.00001 per share.
- F5. Each of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants either provide, or the holder has elected, that the holder shall not have the right to exercise any portion of any such warrants to the extent that after giving effect to such issuance after exercise, such holder and certain of its affiliates would be deemed to beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than a certain percentage of the Issuer's then outstanding shares of common stock (the "Beneficial Ownership Limitations"), as adjusted pursuant to the terms of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants. On September 17, 2026, the Issuer agreed to waive the required 61 days' notice period to the Issuer with respect to an increase in the Beneficial Ownership Limitations under the terms of each of the Pre-Funded Warrants and the Strategic Advisor Warrants held by YZi Labs.
- F6. The Pre-Funded Warrants are immediately exercisable at an initial exercise price equal to $0.00001 per share and may be exercised at any time until the Pre-Funded Warrants are exercised in full, subject to the PFW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Pre-Funded Warrants, the holder may increase or decrease the PFW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 19.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Pre-Funded Warrants is 19.99% of the Issuer's then outstanding shares of Common Stock (the "PFW Beneficial Ownership Limitation"). On September 17, 2026, YZi Labs exercised 5,418,633 Pre-Funded Warrants, representing 5,418,633 shares of Common Stock, at an exercise price of $0.00001 per share.
- F7. The Stapled Warrants are immediately exercisable at an initial exercise price equal to $15.15 per Share and may be exercised at any time on or prior to 5:00 p.m. on June 28, 2028, subject to the SW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Stapled Warrants, the holder may increase or decrease the SW Beneficial Ownership Limitation upon 61 days' notice to the Issuer to any other percentage specified in the notice. As of the date hereof, the Beneficial Ownership Limitation under the Stapled Warrants is 4.99% of the Issuer's then outstanding shares of Common Stock (the "SW Beneficial Ownership Limitation").
Key Figures
Key Terms
Strategic Advisor Warrants financial
Pre-Funded Warrants financial
Beneficial Ownership Limitation financial
Stapled Warrants financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many BNC warrants did YZi Labs exercise, and at what price?
What ownership limits applied to YZi Labs’ BNC warrants?
What other BNC warrants did YZi Labs report?
AI-generated analysis. How Rhea-AI works. Not financial advice.